Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Steben

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
American Journal of Obstetrics and Gynecology|February 21, 2025
An updated understanding of the natural history of cervical human papillomavirus infection-clinical implicationsKathrine D Lycke, Marc Steben, Suzanne M Garland, et al.
Human Vaccines|February 11, 2011
The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassayDarron R Brown, Suzanne M Garland, Daron G Ferris, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 30, 2009
Immunization in pregnancyAndrée Gruslin, Marc Steben, Scott Halperin, et al.
The Cochrane Database of Systematic Reviews|October 1, 2014
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsMarc Arbyn, Andrew Bryant, Philippe Beutels, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2010
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young womenRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
Lancet Regional Health. Americas|November 4, 2024
On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screeningOvidiu Tatar, Ben Haward, Samara Perez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearanceRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Clinical and Vaccine Immunology : CVI|April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccinesSuzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.
The New England Journal of Medicine|May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesSuzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
American Journal of Obstetrics and Gynecology|February 21, 2025
An updated understanding of the natural history of cervical human papillomavirus infection-clinical implicationsKathrine D Lycke, Marc Steben, Suzanne M Garland, et al.
Human Vaccines|February 11, 2011
The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassayDarron R Brown, Suzanne M Garland, Daron G Ferris, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|January 30, 2009
Immunization in pregnancyAndrée Gruslin, Marc Steben, Scott Halperin, et al.
The Cochrane Database of Systematic Reviews|October 1, 2014
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsMarc Arbyn, Andrew Bryant, Philippe Beutels, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 10, 2010
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young womenRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
Lancet Regional Health. Americas|November 4, 2024
On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screeningOvidiu Tatar, Ben Haward, Samara Perez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearanceRalph P Insinga, Gonzalo Perez, Cosette M Wheeler, et al.
International Journal of Cancer|April 15, 2011
Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionRichard M Haupt, Cosette M Wheeler, Darron R Brown, et al.
Clinical and Vaccine Immunology : CVI|April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccinesSuzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.
The New England Journal of Medicine|May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesSuzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.
Pageof 11